Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia

European Journal of Cancer

Volumn 42, Issue 3, 2006, Pages 295-309

  Swerts, Katrien ^a   Moerloose, Barbara De ^a   Dhooge, Catharina ^a   Laureys, Geneviève ^a   Benoit, Yves ^a   Philippé, Jan ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Breast cancer resistance protein; Childhood acute lymphoblastic leukaemia; Lung resistance protein; Multidrug resistance; Multidrug resistance associated protein 1; P glycoprotein

Indexed keywords

BIRICODAR; BISANTRENE; BREAST CANCER RESISTANCE PROTEIN; CHLOROQUINE; CREMOPHOR; CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; EPIPODOPHYLLOTOXIN DERIVATIVE; ERYTHROMYCIN; ETOPOSIDE; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; METHOTREXATE; MITOXANTRONE; MONOCLONAL ANTIBODY MRK 16; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PIMOZIDE; QUININE; RESERPINE; STAUROSPORINE; TAMOXIFEN; TARIQUIDAR; TOPOTECAN; UNINDEXED DRUG; VALSPODAR; VERAPAMIL; VINCA ALKALOID; ZOSUQUIDAR;

ACUTE LYMPHOBLASTIC LEUKEMIA; BODY REGIONS; CHILDHOOD LEUKEMIA; CHROMOSOME 7; CLINICAL TRIAL; DRUG BINDING; DRUG CLEARANCE; DRUG DOSE REDUCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA INTERFERENCE;

EID: 31144473569     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.09.017     Document Type: Article

References (144)

1. J.F. Margolin, and D.G. Poplack Acute lymphoblastic leukemia P. Pizzo D. Poplack Principles and Practice in Pediatric Oncology 1997 Lippincott, Williams & Wilkins Philadelphia 409 462
2. P. Borst Genetic mechanisms of drug resistance: a review Acta Oncol 30 1991 87 105
3. G.D. Kruh Introduction to resistance to anticancer agents Oncogene 22 2003 7262 7264
4. R.L. Juliano, and V. Ling Surface glycoprotein modulating drug permeability in chinese-hamster ovary cell mutants Biochim Biophys Acta 455 1976 152 162
5. S.P.C. Cole, G. Bhardwaj, and J.H. Gerlach Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 1992 1650 1654
6. D.D. Ross Novel mechanisms of drug resistance in leukemia Leukemia 14 2000 467 473
7. T. Litman, M. Brangi, and E. Hudson The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2) J Cell Sci 113 2000 2011 2021
8. K. Kage, S. Tsukahara, and T. Sugiyama Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization Int J Cancer 97 2002 626 630
9. G.L. Scheffer, P.L.J. Wijngaard, and M.J. Flens The drug resistance-related protein LRP is the human major vault protein Nat Med 1 1995 579 582
10. A. Fojo, R. Lebo, and N. Shimizu Localization of multidrug resistance-associated DNA sequences to human chromosome 7 Somat Cell Mol Genet 12 1986 415 420
11. D.F. Callen, E. Baker, and R.N. Simmers Localization of the human multiple drug resistance gene, MDR1, to 7q21.1 Hum Genet 77 1987 142 144
12. J.H. Gerlach, J.A. Endicott, and P.F. Juranka Homology between P-glycoprotein and a bacterial hemolysin transport protein suggests a model for multidrug resistance Nature 324 1986 485 489
13. P. Gros, J. Croop, and D. Housman Mammalian multidrug resistance gene - complete cDNA sequence indicates strong homology to bacterial transport proteins Cell 47 1986 371 380
14. C.J. Chen, J.E. Chin, and K. Ueda Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 47 1987 381 389
15. S.C. Hyde, P. Emsley, and M.J. Hartshorn Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport Nature 346 1990 362 365
16. J.A. Endicott, and V. Ling The biochemistry of P-glycoprotein-mediated multidrug resistance Annu Rev Biochem 58 1990 137 171
17. C.F. Higgins ABC transporters: from microorganisms to man Annu Rev Cell Biol 8 1992 67 113
18. M.M. Gottesman, and I. Pastan Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 62 1993 385 427
19. H. Bolhuis, H.W. vanVeen, and B. Poolman Mechanisms of multidrug transporters FEMS Microbiol Rev 21 1997 55 84
20. C.F. Higgins, and M.M. Gottesman Is the multidrug transporter a flippase Trends Biochem Sci 17 1992 18 21
21. C.F. Higgins Flip-flop: the transmembrane translocation of lipids Cell 79 1994 393 395
22. A.T. Fojo, K. Ueda, and D.J. Slamon Expression of a multidrug-resistance gene in human tumors and tissues Proc Natl Acad Sci USA 84 1987 265 269
23. F. Thiebaut, T. Tsuruo, and H. Hamada Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues Proc Natl Acad Sci USA 84 1987 7735 7738
24. C. Cordon-Cardo, J.P. O'Brien, and D. Casals Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood brain barrier sites Proc Natl Acad Sci USA 86 1989 695 698
25. P.M. Chaudhary, and I.B. Roninson Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells Cell 66 1991 85 94
26. P.M. Chaudhary, E.B. Mechetner, and I.B. Roninson Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes Blood 80 1992 2735 2739
27. J.M. Ford, E.P. Bruggemann, and I. Pastan Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines Cancer Res 50 1990 1748 1756
28. J.M. Ford, and W.N. Hait Pharmacology of drugs that alter multidrug resistance in cancer Pharmacol Rev 42 1990 155 199
29. C. Avendano, and J.C. Menendez Inhibitors of multidrug resistance to antitumor agents (MDR) Curr Med Chem 9 2002 159 193
30. L. Rivoltini, M.P. Colombo, and R. Supino Modulation of multidrug resistance by verapamil or MDR1 antisense oligodeoxynucleotide does not change the high susceptibility to lymphokine activated killers in MDR-resistant human carcinoma (Lovo) line Int J Cancer 46 1990 727 732
31. S.E. Bates, J.S. Lee, and B. Dickstein Differential modulation of P-glycoprotein transport by protein kinase inhibition Biochemistry 32 1993 9156 9164
32. E. Yague, C.F. Higgins, and S. Raguz Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1 Gene Ther 11 2004 1170 1174
33. E.B. Mechetner, and I.B. Roninson Efficient inhibition of P-glycoprotein mediated multidrug resistance with a monoclonal antibody Proc Natl Acad Sci USA 89 1992 5824 5828
34. G.H. Mickisch, L.H. Pai, and M.M. Gottesman Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug resistant transgenic mice Cancer Res 52 1992 4427 4432
35. L.S. Rittmanngrauer, M.A. Yong, and V. Sanders Reversal of vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft Cancer Res 52 1992 1810 1816
36. A.H. Dantzig, D.P. de Alwis, and M. Burgess Considerations in the design and development of transport inhibitors as adjuncts to drug therapy Adv Drug Deliv Rev 55 2003 133 150
37. G.D. Leonard, T. Fojo, and S.E. Bates The role of ABC transporters in clinical practice Oncologist 8 2003 411 424
38. D. Mahadevan, and A.F. List Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies Blood 104 2004 1940 1951
39. Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005 [Epub ahead of print].
40. P. Sonneveld, and A.F. List Chemotherapy resistance in acute myeloid leukaemia Best Pract Res Clin Haematol 14 2001 211 233
41. J.P. Marie, J.N. Bastie, and F. Coloma Cyclosporine A as a modifier agent in the salvage treatment of acute leukemia (AL) Leukemia 7 1993 821 824
42. E. Solary, D. Caillot, and B. Chauffert Feasibility of using quinine, a potential multidrug resistance reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia J Clin Oncol 10 1992 1730 1736
43. H. Thomas, and H.M. Coley Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein Cancer Control 10 2003 159 165
44. N.A. Brophy, J.P. Marie, and V.A. Rojas MDR1 gene expression in childhood acute lymphoblastic leukemias and lymphomas - a critical evaluation by 4 techniques Leukemia 8 1994 327 335
45. H. Hamada, and T. Tsuruo Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies Proc Natl Acad Sci USA 83 1986 7785 7789
46. T. Grogan, W. Dalton, and J. Rybski Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies Lab Invest 63 1990 815 824
47. G. Lehne, P. De Angelis, and O.P. Clausen Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein Cytometry 20 1995 228 237
48. T. Efferth, H. Lohrke, and M. Volm Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine123 in human tumors Anticancer Res 9 1989 1633 1637
49. R.M. Wadkins, and P.J. Houghton Kinetics of transport of dialkyloxacarbocyanines in multidrug-resistant cell lines overexpressing P-glycoprotein: interrelationship of dye alkyl chain length, cellular flux, and drug resistance Biochemistry 34 1995 3858 3872
50. O. Legrand, J.Y. Perrot, and G. Simonin JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia Blood 97 2001 502 508
51. P. Ubezio, M. Limonta, and M. D'Incalci Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphoblastic leukaemia Eur J Cancer Clin Oncol 25 1989 1895 1899
52. Y. Mizuno, T. Hara, and M. Nagata Detection of multidrug resistant protein, P-glycoprotein in childhood leukemia and lymphoma Eur J Pediatr 150 1991 416 418
53. V. Gekeler, G. Frese, and A. Noller MDR1/P-glycoprotein, topoisomerase, and glutathione-S-transferase-pi gene expression in primary and relapsed state adult and childhood leukemias Br J Cancer 66 1992 507 517
54. D. Kingreen, C. Sperling, and M. Notter Sequential analysis of P-glycoprotein expression in childhood acute lymphoblastic leukemia Hematol Blood Transfus 34 1992 23 28
55. R. Pieters, T. Hongo, and A.H. Loonen Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukemia Br J Cancer 65 1992 691 697
56. O. Fenneteau, J.P. Marie, and B. Lescoeur Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia Blood 82 1993 3787 3788
57. J.E. Goasguen, J.M. Dossot, and O. Fardel Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications Blood 81 1993 2394 2398
58. C. Dhooge, B. De Moerloose, and C. De Potter Expression of the multidrug transporter, P-glycoprotein, in childhood leukemia: a prospective clinical study Int J Pediat Hematol Onc 1 1994 311 314
59. A. Sauerbrey, F. Zintl, and M. Volm P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukemia Br J Cancer 70 1994 1144 1149
60. J. Beck, R. Handgretinger, and R. Dopfer Expression of mdr1, mrp, topoisomerase-II-alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukemias Br J Haematol 89 1995 356 363
61. A. Tafuri, A. Sommaggio, and L. Burba Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia Leuk Res 19 1995 927 931
62. S.P. Ivy, R.S. Olshefski, and B.J. Taylor Correlation of P-glycoprotein expression and function in childhood acute leukemia: a Children's Cancer Group Study Blood 88 1996 309 318
63. M. Volm, F. Zintl, and A. Sauerbrey Resistance-related proteins in initial and relapsed childhood acute lymphoblastic leukemia Int J Oncol 8 1996 331 335
64. G. Srinivas, P. Kusumakumari, and M.K. Nair Tumor proliferative compartment, multidrug resistance gene product and apoptosis regulatory p53 and bcl-2 proteins in pediatric acute lymphoblastic leukemia Oncol Rep 4 1997 1083 1087
65. M. Volm, F. Zintl, and L. Edler Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia Med Pediatr Oncol 28 1997 117 126
66. M.L. den Boer, R. Pieters, and K.M. Kazemier Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia Blood 91 1998 2092 2098
67. J. Kanerva, M. Tiirikainen, and A. Makipernaa Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL Pediatr Hematol Oncol 15 1998 11 21
68. S. Gurbuxani, D. Zhou, and G. Simonin Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India Ann Hematol 76 1998 195 200
69. M.L. den Boer, R. Pieters, and K.M. Kazemier Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia Leukemia 13 1999 2023 2030
70. C. Dhooge, B. De Moerloose, and G. Laureys P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study Br J Haematol 105 1999 676 683
71. T. Kakihara, A. Tanaka, and A. Watanabe Expression of multidrug resistance-related genes does not contribute to risk factors in newly diagnosed childhood acute lymphoblastic leukemia Pediatr Int 41 1999 641 647
72. B. Ogretmen, J.C. Barredo, and A.R. Safa Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia J Pediat Hematol Onc 22 2000 45 49
73. S. Gurbuxani, S. Sazawal, and L.S. Arya MDR1 mRNA expression in young patients with acute lymphoblastic leukaemia Br J Haematol 109 2000 897 899
74. C. Wuchter, L. Karawajew, and V. Ruppert Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia Haematologica 85 2000 711 721
75. J. Kanerva, M.I. Tiirikainen, and A. Makipernaa Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up Pediatr Hematol Oncol 18 2001 27 36
76. C. Dhooge, B. De Moerloose, and G. Laureys Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: Results of a long-term prospective study Leuk Lymphoma 43 2002 309 314
77. B. De Moerloose, K. Swerts, and Y. Benoit The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia Pediatr Hematol Oncol 20 2003 381 391
78. S.L.A. Plasschaert, E. Vellenga, and E.S.J.M. De Bont High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children Leuk Lymphoma 44 2003 85 95
79. F. Casale, V. D'Angelo, and R. Addeo P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia Oncol Rep 12 2004 1201 1207
80. N.L. Ramakers-van Woerden, H.B. Beverloo, and A.J.P. Veerman In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype Leukemia 18 2004 521 529
81. R.W. Stam, M.M. Heuvel-Eibrink, and M.L. den Boer Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein Leukemia 18 2004 78 83
82. K. Swerts, B. De Moerloose, and C. Dhooge Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia Leuk Lymphoma 45 2004 2221 2228
83. A.T. Valera, C.A. Scrideli, and R.G. Queiroz Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia Sao Paulo Med J 122 2004 166 171
84. W.T. Beck, T.M. Grogan, and C.L. Willman Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations Cancer Res 56 1996 3010 3020
85. H.J. Broxterman, J. Lankelma, and H.M. Pinedo Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia Leukemia 11 1997 1110 1118
86. J.P. Marie, S. Huet, and A.M. Faussat Multicentric evaluation of the MDR phenotype in leukemia Leukemia 11 1997 1086 1094
87. G. Pall, M. Spitaler, and J. Hofmann Multidrug resistance in acute leukemia: A comparison of different diagnostic methods Leukemia 11 1997 1067 1072
88. T. Efferth Testing for tumor drug resistance in the age of molecular medicine. A contribution to the Debate Round-Table on phenotypic and genotypic analysis of multidrug resistance (MDR) in clinical hospital practice Leukemia 13 1999 1627 1629
89. D. Lautier, Y. Canitrot, and R.G. Deeley Multidrug resistance mediated by the multidrug resistance protein (MRP) gene Biochem Pharmacol 52 1996 967 977
90. E. Bakos, T. Hegedus, and Z. Hollo Membrane topology and glycosylation of the human multidrug resistance-associated protein J Biol Chem 271 1996 12322 12326
91. S. Paul, L.M. Breuninger, and K.D. Tew ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter Proc Natl Acad Sci USA 93 1996 6929 6934
92. C.E. Grant, G. Valdimarsson, and D.R. Hipfner Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs Cancer Res 54 1994 357 361
93. G.J.R. Zaman, M.J. Flens, and M.R. Vanleusden The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump Proc Natl Acad Sci USA 91 1994 8822 8826
94. Z.S. Chen, T. Furukawa, and T. Sumizawa ATP-dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P Mol Pharmacol 55 1999 921 928
95. I. Leier, G. Jedlitschky, and U. Buchholz The MRP gene encodes an ATP-dependent export pump for leukotriene C4, and structurally related conjugates J Biol Chem 269 1994 27807 27810
96. G. Jedlitschky, I. Leier, and U. Buchholz Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump Cancer Res 56 1996 988 994
97. L. Rigato, L. Pascolo, and C. Fernetti The human multidrug-resistance- associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin Biochem J 383 2004 335 341
98. N. Ballatori, C.L. Hammond, and J.B. Cunningham Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins Toxicol Appl Pharmacol 204 2005 238 255
99. E. Schneider, H. Yamazaki, and B.K. Sinha Buthionine Sulfoximine-Mediated Sensitization of Etoposide-Resistant Human Breast-Cancer Mcf7 Cells Overexpressing the Multidrug Resistance-Associated Protein Involves Increased Drug Accumulation Br J Cancer 71 1995 738 743
100. C.H.M. Versantvoort, H.J. Broxterman, and T. Bagrij Regulation by glutathione of drug transport in multidrug resistant human lung tumor cell lines overexpressing multidrug resistance-associated protein Br J Cancer 72 1995 82 89
101. G.J.R. Zaman, J. Lankelma, and O. Vantellingen Role of Glutathione in the Export of Compounds from Cells by the Multidrug-Resistance-Associated Protein Proc Natl Acad Sci USA 92 1995 7690 7694
102. Q.C. Mao, R.G. Deeley, and S.P.C. Cole Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles J Biol Chem 275 2000 34166 34172
103. A. Lorico, G. Rappa, and R.A. Finch Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione Cancer Res 57 1997 5238 5242
104. G. Rappa, A. Lorico, and R.A. Flavell Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural produce toxins Cancer Res 57 1997 5232 5237
105. V. Gekeler, W. Ise, and K.H. Sanders The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance Biochem Biophys Res Commun 208 1995 345 352
106. U. Vanhoefer, S.S. Cao, and H. Minderman D,L-buthionine- (S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors Clin Cancer Res 2 1996 1961 1968
107. M. Salerno, and A. Garnier-Suillerot Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells Eur J Pharmacol 421 2001 1 9
108. E.M. Leslie, K. Ito, and P. Upadhyaya Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog J Biol Chem 276 2001 27846 27854
109. Y.M. Qian, W.C. Song, and H. Cui Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1 J Biol Chem 276 2001 6404 6411
110. D.W. Loe, R.G. Deeley, and S.P.C. Cole Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1) J Pharmacol Exp Ther 293 2000 530 538
111. D.W. Loe, C.J. Oleschuk, and R.G. Deeley Structure-activity studies of verapamil analogs that modulate transport of leukotriene C-4 and reduced glutathione by multidrug resistance protein MRP1 Biochem Biophys Res Commun 275 2000 795 803
112. K.V. Cullen, R.A. Davey, and M.W. Davey Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells Biochem Pharmacol 62 2001 417 424
113. E.M. Leslie, R.G. Deeley, and S.P.C. Cole Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1) Drug Metab Dispos 31 2003 11 15
114. M. Salerno, P. Loechariyakul, and C. Saengkhae Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRP1-mediated efflux of daunorubicin Biochem Pharmacol 68 2004 2159 2165
115. M.J. Flens, G.J.R. Zaman, and P. Vandervalk Tissue distribution of the multidrug resistance protein Am J Pathol 148 1996 1237 1247
116. A.T. Nies, G. Jedlitschky, and J. Konig Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain Neuroscience 129 2004 349 360
117. A. Sauerbrey, A. Voigt, and S. Wittig Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia Leuk Lymphoma 43 2002 875 879
118. Y.N. Chen, L.A. Mickley, and A.M. Schwartz Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein J Biol Chem 265 1990 10073 10080
119. L.A. Doyle, W. Yang, and L.V. Abruzzo A multidrug resistance transporter from human MCF-7 breast cancer cells Proc Natl Acad Sci USA 95 1998 15665 15670
120. R. Allikmets, L.M. Schriml, and A. Hutchinson A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Res 58 1998 5337 5339
121. S.K. Rabindran, H.Y. He, and M. Singh Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C Cancer Res 58 1998 5850 5858
122. R.W. Robey, W.Y. Medina-Perez, and K. Nishiyama Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells Clin Cancer Res 7 2001 145 152
123. E.L. Volk, K.M. Farley, and Y. Wu Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance Cancer Res 62 2002 5035 5040
124. Y. Honjo, C.A. Hrycyna, and Q.W. Yan Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells Cancer Res 61 2001 6635 6639
125. M. Maliepaard, G.L. Scheffer, and I.F. Faneyte Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res 61 2001 3458 3464
126. A. Sauerbrey, W. Sell, and D. Steinbach Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia Br J Haematol 118 2002 147 150
127. R.J. Scheper, H.J. Broxterman, and G.L. Scheffer Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein mediated multidrug resistance Cancer Res 53 1993 1475 1479
128. M.L. Slovak, J.P. Ho, and S.P.C. Cole The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification Cancer Res 55 1995 4214 4219
129. D.C. Chugani, L.H. Rome, and N.L. Kedersha Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex J Cell Sci 106 1993 23 29
130. M.A. Izquierdo, G.L. Scheffer, and M.J. Flens Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors Am J Pathol 148 1996 877 887
131. A.C. Siva, S. Raval-Fernandes, and A.G. Stephen Up-regulation of vaults may be necessary but not sufficient for multidrug resistance Int J Cancer 92 2001 195 202
132. A. van Zon, M.H. Mossink, and M. Schoester Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression Cancer Res 64 2004 4887 4892
133. M.H. Mossink, A. van Zon, and E. Franzel-Luiten Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics Cancer Res 62 2002 7298 7304
134. K.E. Huffman, and D.R. Corey Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line Biochemistry 44 2005 2253 2261
135. M. Kitazono, H. Okumura, and R. Ikeda Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells Int J Cancer 91 2001 126 131
136. M. Volm, G. Stammler, and F. Zintl Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia Anticancer Drugs 8 1997 662 665
137. J.J. Neefjes, F. Momburg, and G.J. Hammerling Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter Science 261 1993 769 771
138. S. Childs, R.L. Yeh, and E. Georges Identification of a sister gene to P-glycoprotein Cancer Res 55 1995 2029 2034
139. A. Haimeur, G. Conseil, and R.G. Deeley The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation Curr Drug Metabol 5 2004 21 53
140. D. Steinbach, S. Wittig, and G. Cario The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype Blood 102 2003 4493 4498
141. M. Pallis, J. Fisher, and L. Truran Reproducible measurements of AML blast p-glycoprotein function in 2 center analyses Blood 105 2005 1367 1368
142. J.P. Annereau, G. Szakacs, and C.J. Tucker Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance Mol Pharmacol 66 2004 1397 1405
143. J.P. Gillet, T. Efferth, and D. Steinbach Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes Cancer Res 64 2004 8987 8993
144. A. Holleman, M.H. Cheok, and M.L. den Boer Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment N Engl J Med 351 2004 533 542